MedTrace Logo

Platelet Rich Plasma (PRP) in Total Knee Replacement

NCT00826098 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-09-01

No results posted yet for this study

Summary

Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).

Conditions

Interventions

BIOLOGICAL

Platelet Rich Plasma

Addition of PRP to total knee replacement procedure

Sponsors & Collaborators

  • Exactech

    lead INDUSTRY

Principal Investigators

  • Wayne Moody, MD · Central Maine Orthopaedics, PA

  • Pasquale Petrera, MD · Peninsula Orthopedic Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-06-30
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00826098 on ClinicalTrials.gov